Triclosan: Applications and safety

American Journal of Infection Control

Volumn 24, Issue 3, 1996, Pages 209-218

  Bhargava, H N ^a   Leonard, Patricia A ^a  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; CHLOROXYLENOL; DEODORANT AGENT; DISINFECTANT AGENT; GLUCONIC ACID; SOAP; TOOTHPASTE; TRICLOSAN;

ANTIMICROBIAL ACTIVITY; CARCINOGENICITY; CHRONIC TOXICITY; DRUG ABSORPTION; DRUG METABOLISM; DRUG SAFETY; EYE IRRITATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MUTAGENICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; REVIEW; SKIN IRRITATION; SKIN SENSITIZATION; TERATOGENICITY; TOOTH PLAQUE; TOPICAL DRUG ADMINISTRATION;

EID: 0029901844     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-6553(96)90017-6     Document Type: Article

References (28)

1. Jungermann E, Taber D. A new broad spectrum antibacterial soap, I: general properties. J Am Oil Chem 1971; 48:318-25.
2. Regos J, Zak O, Solf R, Visher WA, Weirich EG. Antimicrobial spectrum of triclosan, a broad spectrum antimicrobial agent for topical application, II: comparison with other antibacterial agents. Dermatologica 1979; 158:72-9.
3. Jackson RJ, Smith F. The effect of dentifrices containing triclosan on plaque growth. British Society of Dental Research 1987;(Abs. 300).
4. Patomo F, Wantland L, Sanchez A, Devizio W, Caster W, Baines E. The effect of a dentifrice containing triclosan and copolymer on plaque formation and gingivitis. Am J Dent 1989;2:231-6.
5. Larson E, Butz AM, Gillette DL, Laughton BA. Alcohol for surgical scrubbing. Infect Control Hosp Epidemiol 1990; 3:139-43.
6. Vischer WA, Regos J. Antimicrobial spectrum of triclosan a broad spectrum antimicrobial agent. Zentralbl Bakteriol [Orig A] 1974;226:376-89.
7. Regos J, Hitz HR. Investigations on the mode of action of triclosan, a broad spectrum antimicrobial agent. Zentralbl Bakteriol [Orig A] 1974;226:390-401.
8. Meincke BE, Krantz RG, Lynch DL. Effect of Irgasan on bacterial growth and its adsorption into the cell wall. Microbios 1980;28:113-14,133-48.
9. Lilly HA, Lowbury EJL. Dinsinfection of the skin with detergent preparations of Irgasan and other antiseptics. Br Med J 1974;4:372-4.
10. Imokawa G, Harou S, Kikuhiko O. Antimicrobial effect of zinc pyrithione. J Soc Cos Chem 1982;33:27-37.
11. Cox A. Efficacy of the antimicrobial agent triclosan in topical deodorant products:Recent developments in vivo. J Soc Cos Chem 1987;38:223-31.
12. Larson E. Handwashing: its essential even when you use gloves. Am J Nurs 1989:934-9.
13. Ayliffe GAJ, Babb JR, Davies JG, Lilly HA. Hand disinfection: a comparison of various agents in laboratory and ward studies. J Hosp Infect 1988;11:226-43.
14. Bartzokas CA, Corkill JE, Makin T, Finder DC. Assessment of the remuent antibacterial effect of a 2% triclosandetergent preparation on the skin. J Hyg Camb 1983;91: 521-8.
15. Bartzokas CA, Payton JH, Gibson MF, Graham R, McLoughlin GA, Croton RS. Control and eradication of methicillin-resistent Staphlococcus aureus on a surgical unit. N Engl J Med 1984;311:1422-5.
16. Webster J. Handwashing in a neonatal intensive care unit: product acceptibility and effectiveness of chlorhexidine gluconate 4% and triclosan 1%. J Hosp Infect 1992;21:137-41.
17. Saxton C, Svatum B, Lloyd AM. Antiplaque effects and mode of action of a combination of zinc citrate and a noninonic antimicrobial agent. Scand J Dent Res 1988; 96:212-7.
18. Wade W, Addy M. Antibacterial activity of some triclosancontaining toothpastes and their ingredients. J Periodontol 1992;63:280-2.
19. Lobene RR, Battista AW, Petrone DM, Volpe AR, Petrone JD. Clinical efficacy of an anticalculus fluoride dentifrice. Am J Dent 1991;4:83-5.
20. Rustogi KM, Petrone DM, Singh SM. Clinical study of a pre-brush rinse and a triclosan/copolymer mouthrinse: effect on plaque formation. Am J Dent 1991;3:567-9.
21. Desalva SJ, Kong BM, Lin YJ. Triclosan: a safety profile. Am J Dent 1989;2:185-96.
22. Kanetoshi A, Katsura E, Ogawa H, OhyamaT, Kaneshima H, Miura T. Acute toxicity, percutaneous absorption and effects on hepatic mixed function oxidase activities of 2,4,4′trichloro-2′-hydroxydiphenyl ether(Irgasan DP 300) and its chlorinated derivatives. Arch Environ Contam Toxicol 1992;23:91-8.
23. Marzulli FN, Maibach HI. Antimicrobials: experimental contact sensitization in man. J Soc Cos Chem 1973;24: 399-421.
24. Steinkjer B, Braathen L. Contact dermatitis from triclosan (Irgasan DP 300). Contact Dermatitis 1988;18: 243-4.
25. Veronisi S, De Padova MP, Vanni D, Melino M. Contact dermatitis to triclosan. Contact Dermatitis 1986;15:257.
26. Black JG, Howes D. Rutherford T. Percutaneous absorption and metabolism of Irgasan DP 300. Toxicology 1975;3:33-47.
27. Anderson K, Nilsson CA, Rappe C. Studies on chlorinated phenoxyphenols (predioxins). Environ Qual Saf 1975; 3(Suppl):731-3.
28. Black JG, Howes D. Percutaneous absorption of triclosan from toilet preparations. J Soc Cosm Chem 1975;26:205-15.